Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 2/20 | 0.67 |
| ▸ | DRD2 | P14416 | 2/20 | 0.67 |
| ▸ | LMNA | P02545 | 2/20 | 0.58 |
| ▸ | GAA | P10253 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | BLM | P54132 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | LIPE | Q05469 | 1/20 | 0.55 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.53 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13009602 | 0.93 | HTR1A (0.74) | HTR1ADRD2LMNAGAAMAPT | |
| SCHEMBL2985019 | 0.89 | CARM1 (0.55) | HTR1ADRD2LMNAGAAMAPT | |
| SCHEMBL5641766 | 0.85 | MAPT (0.61) | HTR1ADRD2GAAMAPTL3MBTL1 | |
| SCHEMBL9302604 | 0.85 | HTR1A (0.54) | HTR1ADRD2LMNAGAAMAPT | |
| SCHEMBL5940740 | 0.85 | HTR1A (0.54) | HTR1ADRD2LMNAGAAMAPT | |
| SCHEMBL6832292 | 0.85 | HTR1A (0.50) | HTR1ADRD2LMNAGAAMAPT | |
| SCHEMBL3268053 | 0.85 | HTR1A (0.73) | HTR1ADRD2LMNAGAAMAPT | |
| SCHEMBL13986128 | 0.84 | HTR1A (0.53) | HTR1ADRD2LMNAGAAMAPT | |
| SCHEMBL596532 | 0.84 | HTR1A (0.53) | HTR1ADRD2LMNAGAAMAPT | |
| SCHEMBL411706 | 0.84 | L3MBTL1 (0.71) | HTR1ADRD2LMNAGAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 235 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118112898-A | Photoresist stripping liquid and application thereof | 芝普企业股份有限公司 | 2024-05-31 | — | — | CN | claimed |
| EP-3546486-A1 | METHOD OF SOLID-STATE PEPTIDE SYNTHESIS USING A POLYMERIC SUPPORT | Institute of Chemical Process Fundamentals of the CAS, v. v. i. (CZ) | 2019-10-02 | — | — | EP | claimed |
| US-20190292219-A1 | METHOD OF SOLID-STATE PEPTIDE SYNTHESIS USING A NOVEL POLYMERIC SUPPORT | Institute of Chemical Process Fundamentals of the CAS, v.v.i. (CZ) | 2019-09-26 | — | — | US | claimed |
| CN-101663620-A | Low etch cleaning composition for removing resist | ANJI MICROELECTRONICS SHANGHAI | 2010-03-03 | — | — | CN | claimed |
| CN-101652718-A | Cleaning composition for removing thick film resist | ANJI MICROELECTRONICS CO LTD | 2010-02-17 | — | — | CN | claimed |
| US-20060046245-A1 | Porous device | MILLENNIUM PHARMACEUTICALS LIMITED (GB) | 2006-03-02 | — | — | US | claimed |
| US-20260021192-A1 | PROTEINS HAVING A COVALENT WARHEAD | TOPAZ THERAPEUTICS INC (US) | 2026-01-22 | — | — | US | disclosed |
| WO-2025245288-A1 | NON-NATURALLY OCCURRING MELANOCORTIN ANALOGS AND USES THEREOF | ENDEVICA BIO, INC. (US) | 2025-11-27 | — | — | WO | disclosed |
| WO-2025245258-A1 | NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR AGONIST ANALOGS FOR MODULATING WEIGHT GAIN | ENDEVICA BIO, INC. (US) | 2025-11-27 | — | — | WO | disclosed |
| CN-117106057-B | High-purity human adrenocorticotropic hormone or analogue thereof and large-scale preparation method thereof | 南京汉欣医药科技有限公司 | 2024-11-01 | — | — | CN | disclosed |
| CN-113307772-B | Human plasma kallikrein inhibitors | 拜奥克里斯特制药公司 | 2024-06-28 | — | — | CN | disclosed |
| CN-118112898-A | Photoresist stripping liquid and application thereof | 芝普企业股份有限公司 | 2024-05-31 | — | — | CN | disclosed |
| US-20240150396-A1 | INHIBITORS OF CYSTEINE PROTEASES | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2024-05-09 | — | — | US | disclosed |
| EP-0309898-A2 | Method for the induction of a cytotoxic T cell response | F. HOFFMANN-LA ROCHE AG (CH) | 1989-04-05 | — | — | EP | disclosed |
| US-4703052-A | Hypoglycemic thiazolidinediones | PFIZER INC. (US) | 1987-10-27 | — | — | US | disclosed |
| EP-0220054-A2 | Ethanolamine derivatives | GLAXO GROUP LIMITED (GB) | 1987-04-29 | — | — | EP | disclosed |
| EP-0207605-A1 | Hypoglycemic thiazolidinediones | PFIZER INC. (US) | 1987-01-07 | — | — | EP | disclosed |
| WO-1986007056-A1 | HYPOGLYCEMIC THIAZOLIDINEDIONES | PFIZER INC. (US) | 1986-12-04 | — | — | WO | disclosed |
| US-4218479-A | Novel benzylalcohols and pharmaceutical compositions and use thereof | TANABE SEIYAKU CO., LTD. (JP) | 1980-08-19 | — | — | US | disclosed |
| US-4218479-A | Novel benzylalcohols and pharmaceutical compositions and use thereof | TANABE SEIYAKU CO., LTD. (JP) | 1980-08-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240150396-A1 | INHIBITORS OF CYSTEINE PROTEASES | CTRL, SERPINB1, PRSS1 | HTR1A 4402/4885DRD2 4850/4885LMNA 3730/4885 |
| US-20260021192-A1 | PROTEINS HAVING A COVALENT WARHEAD | RIOX2, ORC3, DCLRE1A | HTR1A 4144/4885DRD2 4539/4885LMNA 2336/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.